Novo is a loser. Novo, if approved, will likely be expensive. Most importantly, the other dry eye products on the market have distinct advantages over Novo. Novo will flounder (just like many of the other significant seven products. (I enjoyed listening to several of the analysts cut into Papa the Clown.)). I am happy that Papa will be B+L's CEO. He is the perfect for you. B+L and Papa is like Poop and Pee.
